0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Effect of Trimethoprim on Lamivudine Bioavailability-Reply

Christine Katlama, MD
JAMA. 1996;276(14):1140. doi:10.1001/jama.1996.03540140028021.
Text Size: A A A
Published online

In Reply.  —Trimethoprim increases the lamivudine area-under-the-curve (AUC) because of competition for renal excretion through the organic cationic transport system in the kidneys. While it is tempting to consider lower doses of lamivudine in combination with trimethoprim to reduce the cost of antiretroviral regimens, this approach is inappropriate because the bioavailability of lamivudine has a high interpatient variability (mean, 86%; range, 53%-105%),1 and the interpatient variability for the lamivudine AUC when it is administered with trimethoprim-sulfamethoxazole is also high at 44% (SD, 23%).2Monitoring blood levels of lamivudine to ensure adequate exposure to the drug would outweigh the benefits of a simple oral dosing regimen. Moreover, the clearance of other medications that are renally excreted by the organic cationic transport system would be affected by the routine use of trimethoprim to enhance lamivudine levels. While the increased blood levels of lamivudine are not associated with any increased risk of adverse

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();